http://kulan.cz/index.php?action=history&feed=atom&title=Syst%C3%A9mov%C3%A1_hypertenze 2026-05-03T05:36:57Z Historie editací této stránky MediaWiki 1.15.1 http://kulan.cz/index.php?title=Syst%C3%A9mov%C3%A1_hypertenze&diff=9809&oldid=prev 2025-01-12T22:50:49Z

<p><span class="autocomment">Antihypertenziva II. třídy</span></p> <table style="background-color: white; color:black;"> <col class='diff-marker' /> <col class='diff-content' /> <col class='diff-marker' /> <col class='diff-content' /> <tr valign='top'> <td colspan='2' style="background-color: white; color:black;">← Starší verze</td> <td colspan='2' style="background-color: white; color:black;">Verze z 12. 1. 2025, 22:50</td> </tr> <tr><td colspan="2" class="diff-lineno">Řádka 145:</td> <td colspan="2" class="diff-lineno">Řádka 145:</td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* '''Centrálně působící látky &nbsp;</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* '''Centrálně působící látky &nbsp;</div></td></tr> <tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div>rimenidin, moxonidin - v <del class="diffchange diffchange-inline">kombinaci se základní řadou</del>, <del class="diffchange diffchange-inline">vazodilatace periferních cévách </del></div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>rimenidin <ins class="diffchange diffchange-inline">(''Tenaxum'')</ins>, moxonidin <ins class="diffchange diffchange-inline">(''Cynt'') </ins>- <ins class="diffchange diffchange-inline">stimulace imidazolových receptorů - sníží symopatikotonii </ins>v <ins class="diffchange diffchange-inline">CNS (snížení produkce noradrenalinu v mozkovém kmeni) + zvyšují vylučování sodíku ledvinami </ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>&#160;</div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">jsou kontraindikované u srdečního selhání (ve studii zvyšovaly mortalitu)</ins>, <ins class="diffchange diffchange-inline">u těžkých depresí, mohou způsobovat sucho v ústech </ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>&#160;</div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">obecně antihypertenzivum až poslední voby</ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>&#160;</div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>&#160;</div></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr> <tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div><del style="color: red; font-weight: bold; text-decoration: none;">+ stimulace imidazolových receptorů - sníží symopatikotonii v CNS</del></div></td><td colspan="2">&nbsp;</td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>moyonisin - KI sick sinus syndrom, brasykardie, AV blok II-III, srdeční selhání</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>moyonisin - KI sick sinus syndrom, brasykardie, AV blok II-III, srdeční selhání</div></td></tr> <!-- diff generator: internal 2026-05-03 05:36:57 --> </table>

Kulan http://kulan.cz/index.php?title=Syst%C3%A9mov%C3%A1_hypertenze&diff=9169&oldid=prev 2023-09-16T10:13:16Z

<p></p> <table style="background-color: white; color:black;"> <col class='diff-marker' /> <col class='diff-content' /> <col class='diff-marker' /> <col class='diff-content' /> <tr valign='top'> <td colspan='2' style="background-color: white; color:black;">← Starší verze</td> <td colspan='2' style="background-color: white; color:black;">Verze z 16. 9. 2023, 10:13</td> </tr> <tr><td colspan="2" class="diff-lineno">Řádka 31:</td> <td colspan="2" class="diff-lineno">Řádka 31:</td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>kontroly po 3 měsících nebo 6 (u monoterapie) &nbsp;</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>kontroly po 3 měsících nebo 6 (u monoterapie) &nbsp;</div></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;"></ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;">léčba nadváhy - pokles 1 kg sníží o cca 1 mmHg </ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;"></ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;">denně do 5 g NaCl, nepřisolovat </ins></div></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr> <!-- diff generator: internal 2026-05-03 05:36:57 --> </table>

Kulan http://kulan.cz/index.php?title=Syst%C3%A9mov%C3%A1_hypertenze&diff=8985&oldid=prev 2021-07-13T22:39:18Z

<p><span class="autocomment">Antihypertenziva II. třídy</span></p> <table style="background-color: white; color:black;"> <col class='diff-marker' /> <col class='diff-content' /> <col class='diff-marker' /> <col class='diff-content' /> <tr valign='top'> <td colspan='2' style="background-color: white; color:black;">← Starší verze</td> <td colspan='2' style="background-color: white; color:black;">Verze z 13. 7. 2021, 22:39</td> </tr> <tr><td colspan="2" class="diff-lineno">Řádka 157:</td> <td colspan="2" class="diff-lineno">Řádka 157:</td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>působí snížení preloadu i afterloadu, bez větší reflektorické tachykardie</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>působí snížení preloadu i afterloadu, bez větší reflektorické tachykardie</div></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr> <tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div>bolus 25–50 mg, dále kontinuálně 2-18 mg/hod</div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>bolus 25–50 mg, dále kontinuálně 2-18 mg/hod &nbsp;</div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>&#160;</div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">(2 amp á 50 mg/10ml + FR ad 50 ml do perfuzoru, max rychlost 10 ml/hod)</ins></div></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr> <!-- diff generator: internal 2026-05-03 05:36:57 --> </table>

Kulan http://kulan.cz/index.php?title=Syst%C3%A9mov%C3%A1_hypertenze&diff=8810&oldid=prev 2018-06-03T21:54:42Z

<p></p> <table style="background-color: white; color:black;"> <col class='diff-marker' /> <col class='diff-content' /> <col class='diff-marker' /> <col class='diff-content' /> <tr valign='top'> <td colspan='2' style="background-color: white; color:black;">← Starší verze</td> <td colspan='2' style="background-color: white; color:black;">Verze z 3. 6. 2018, 21:54</td> </tr> <tr><td colspan="2" class="diff-lineno">Řádka 234:</td> <td colspan="2" class="diff-lineno">Řádka 234:</td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr> <tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div>[[category:<del class="diffchange diffchange-inline">Dušnost a bolest na hrudi</del>]]</div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>[[category:<ins class="diffchange diffchange-inline">Kardiologie</ins>]] &nbsp;</div></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>[[category:Interna]]</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>[[category:Interna]]</div></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>[[category:Farmakologie]]</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>[[category:Farmakologie]]</div></td></tr> <!-- diff generator: internal 2026-05-03 05:36:57 --> </table>

Kulan http://kulan.cz/index.php?title=Syst%C3%A9mov%C3%A1_hypertenze&diff=8092&oldid=prev 2018-04-16T19:19:29Z

<p><span class="autocomment">Antihypertenziva II. třídy</span></p> <table style="background-color: white; color:black;"> <col class='diff-marker' /> <col class='diff-content' /> <col class='diff-marker' /> <col class='diff-content' /> <tr valign='top'> <td colspan='2' style="background-color: white; color:black;">← Starší verze</td> <td colspan='2' style="background-color: white; color:black;">Verze z 16. 4. 2018, 19:19</td> </tr> <tr><td colspan="2" class="diff-lineno">Řádka 144:</td> <td colspan="2" class="diff-lineno">Řádka 144:</td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>+ stimulace imidazolových receptorů - sníží symopatikotonii v CNS</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>+ stimulace imidazolových receptorů - sníží symopatikotonii v CNS</div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;"></ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;">moyonisin - KI sick sinus syndrom, brasykardie, AV blok II-III, srdeční selhání</ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;"></ins></div></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>alfa-metyldopa - metabolizován na akt. metabolit alfa-metylnoradrenalin, ten stimuluje inhibiční presympat. rec. alfa2 v CNS &nbsp;</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>alfa-metyldopa - metabolizován na akt. metabolit alfa-metylnoradrenalin, ten stimuluje inhibiční presympat. rec. alfa2 v CNS &nbsp;</div></td></tr> <!-- diff generator: internal 2026-05-03 05:36:57 --> </table>

Kulan http://kulan.cz/index.php?title=Syst%C3%A9mov%C3%A1_hypertenze&diff=7757&oldid=prev 2018-01-28T22:42:06Z

<p><span class="autocomment">Antihypertenziva II. třídy</span></p> <table style="background-color: white; color:black;"> <col class='diff-marker' /> <col class='diff-content' /> <col class='diff-marker' /> <col class='diff-content' /> <tr valign='top'> <td colspan='2' style="background-color: white; color:black;">← Starší verze</td> <td colspan='2' style="background-color: white; color:black;">Verze z 28. 1. 2018, 22:42</td> </tr> <tr><td colspan="2" class="diff-lineno">Řádka 148:</td> <td colspan="2" class="diff-lineno">Řádka 148:</td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr> <tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div>uradipil - nejsilnější antihypertenzivum vůbec<del class="diffchange diffchange-inline">, </del>alfa1 blokáda - periferní vazodilatace &nbsp;</div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>uradipil <ins class="diffchange diffchange-inline">''Ebrantil'' </ins>- nejsilnější antihypertenzivum vůbec &nbsp;</div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">* </ins>alfa1 blokáda - periferní vazodilatace &nbsp;</div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">* zároveň stimulace 5-HT receptorů v CNS -&gt; snížení sympatikotonie v CNS</ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>&#160;</div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">působí snížení preloadu i afterloadu, bez větší reflektorické tachykardie</ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>&#160;</div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">bolus 25–50 mg, dále kontinuálně 2-18 mg/hod</ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>&#160;</div></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr> <tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div><del style="color: red; font-weight: bold; text-decoration: none;">+ stimulace 5-HT receptorů v CNS -&gt; snížení sympatikotonie v CNS</del></div></td><td colspan="2">&nbsp;</td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr> <!-- diff generator: internal 2026-05-03 05:36:57 --> </table>

Kulan http://kulan.cz/index.php?title=Syst%C3%A9mov%C3%A1_hypertenze&diff=5045&oldid=prev 2011-10-29T00:01:41Z

<p></p> <table style="background-color: white; color:black;"> <col class='diff-marker' /> <col class='diff-content' /> <col class='diff-marker' /> <col class='diff-content' /> <tr valign='top'> <td colspan='2' style="background-color: white; color:black;">← Starší verze</td> <td colspan='2' style="background-color: white; color:black;">Verze z 29. 10. 2011, 00:01</td> </tr> <tr><td colspan="2" class="diff-lineno">Řádka 20:</td> <td colspan="2" class="diff-lineno">Řádka 20:</td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>** ledviny - vaskulární nefroskleróza -&gt; mikroalbuminurie (každému hypertonikovi vyšetřit moč) &nbsp;</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>** ledviny - vaskulární nefroskleróza -&gt; mikroalbuminurie (každému hypertonikovi vyšetřit moč) &nbsp;</div></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>** cévy - ateroskleróza velkých cév - kalcifikace aorty, disekce aorty (hrudní, descendentí, břišní) (u Marfana je ascendentní)</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>** cévy - ateroskleróza velkých cév - kalcifikace aorty, disekce aorty (hrudní, descendentí, břišní) (u Marfana je ascendentní)</div></td></tr> <tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div>* <del class="diffchange diffchange-inline">II° </del>- selhání funkce (ICHS<del class="diffchange diffchange-inline">.. </del></div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>* <ins class="diffchange diffchange-inline">III° </ins>- selhání funkce (ICHS<ins class="diffchange diffchange-inline">, selhání LK, CMP, snížení GF)</ins></div></td></tr> <tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div>* IV°-&nbsp; &nbsp;</div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>* IV°-&nbsp; <ins class="diffchange diffchange-inline">maligní hypertenze (těžká hypertenze s akcentací org.změn - zvl.neuroretinopatie, ledviny</ins></div></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>prognóza HT záleží na TK po léčbě (ne před léčbou) &nbsp;</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>prognóza HT záleží na TK po léčbě (ne před léčbou) &nbsp;</div></td></tr> <tr><td colspan="2" class="diff-lineno">Řádka 198:</td> <td colspan="2" class="diff-lineno">Řádka 198:</td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* amlodipin - (''Agen'') BKK, 5-10 mg &nbsp;</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* amlodipin - (''Agen'') BKK, 5-10 mg &nbsp;</div></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr> <tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div>* nitroprusid sodný - anorganická komplexní sůl trojmocného železa obsahující NO - arteriodilatace</div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>* nitroprusid sodný - anorganická komplexní sůl trojmocného železa obsahující NO - arteriodilatace <ins class="diffchange diffchange-inline">0,3 - 0,8 ug/kg/min</ins></div></td></tr> <tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div>* urapidil - aktivace 5-HT&lt;sub&gt;1A&lt;/sub&gt; receptorů v oblongatě (sníží aktivitu sympatiku) + alfa1 blokátor (sníží cévní rezistenci)</div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>* urapidil - aktivace 5-HT&lt;sub&gt;1A&lt;/sub&gt; receptorů v oblongatě (sníží aktivitu sympatiku) + alfa1 blokátor (sníží cévní rezistenci) <ins class="diffchange diffchange-inline">(nedávat u hypertenzní encefalopatie) 25 mg, dále do 100 mg </ins></div></td></tr> <tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div>* labetolol - lipofilní neselektivní beta-blokátor se slabou ISA</div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>* labetolol - lipofilní neselektivní beta-blokátor se slabou ISA <ins class="diffchange diffchange-inline">- bolus i.v. 20-40 mg 1 min., pak 1-2 mg/min. (ne u dysfce LK)</ins></div></td></tr> <tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div>* nitráty &nbsp;</div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>* nitráty <ins class="diffchange diffchange-inline">ISDN 2-10 mg/h., NTG 0,5-10 mg/h (optim.u IM,NAP)</ins></div></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* furosemid &nbsp;</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* furosemid &nbsp;</div></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr> <!-- diff generator: internal 2026-05-03 05:36:57 --> </table>

Kulan http://kulan.cz/index.php?title=Syst%C3%A9mov%C3%A1_hypertenze&diff=5044&oldid=prev 2011-10-28T23:55:12Z

<p></p> <table style="background-color: white; color:black;"> <col class='diff-marker' /> <col class='diff-content' /> <col class='diff-marker' /> <col class='diff-content' /> <tr valign='top'> <td colspan='2' style="background-color: white; color:black;">← Starší verze</td> <td colspan='2' style="background-color: white; color:black;">Verze z 28. 10. 2011, 23:55</td> </tr> <tr><td colspan="2" class="diff-lineno">Řádka 79:</td> <td colspan="2" class="diff-lineno">Řádka 79:</td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>perioperační HT - chirurgové vysadí vše před operací, bolest zvýší tlak</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>perioperační HT - chirurgové vysadí vše před operací, bolest zvýší tlak</div></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr> <tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div>'''sekundární HT''' - je jich <del class="diffchange diffchange-inline">10</del>%, více u mladších lidí, je rezistentnější na terapii &nbsp;</div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>'''sekundární HT''' - je jich <ins class="diffchange diffchange-inline">asi 5</ins>%, více u mladších lidí, je rezistentnější na terapii &nbsp;</div></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* NSA, kortikosteroidy &nbsp;</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* NSA, kortikosteroidy &nbsp;</div></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* estrogeny ve velkých dávkách, hormonální antikoncepce &nbsp;</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* estrogeny ve velkých dávkách, hormonální antikoncepce &nbsp;</div></td></tr> <!-- diff generator: internal 2026-05-03 05:36:57 --> </table>

Kulan http://kulan.cz/index.php?title=Syst%C3%A9mov%C3%A1_hypertenze&diff=5043&oldid=prev 2011-10-28T23:53:15Z

<p></p> <table style="background-color: white; color:black;"> <col class='diff-marker' /> <col class='diff-content' /> <col class='diff-marker' /> <col class='diff-content' /> <tr valign='top'> <td colspan='2' style="background-color: white; color:black;">← Starší verze</td> <td colspan='2' style="background-color: white; color:black;">Verze z 28. 10. 2011, 23:53</td> </tr> <tr><td colspan="2" class="diff-lineno">Řádka 79:</td> <td colspan="2" class="diff-lineno">Řádka 79:</td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>perioperační HT - chirurgové vysadí vše před operací, bolest zvýší tlak</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>perioperační HT - chirurgové vysadí vše před operací, bolest zvýší tlak</div></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr> <tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div>'''sekundární HT''' - je jich <del class="diffchange diffchange-inline">90</del>%, více u mladších lidí, je rezistentnější na terapii &nbsp;</div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>'''sekundární HT''' - je jich <ins class="diffchange diffchange-inline">10</ins>%, více u mladších lidí, je rezistentnější na terapii &nbsp;</div></td></tr> <tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div>* NSA, kortikosteroidy, <del class="diffchange diffchange-inline">glukokortikoidy</del></div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>* NSA, kortikosteroidy &nbsp;</div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">* estrogeny ve velkých dávkách, hormonální antikoncepce </ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">* katecholaminy na astma</ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">* koarktace aorty, adrenogenitální syndromy </ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">* glomerulonefritidy, pyelonefritidy, polycystické ledviny </ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">* vasorenální hypertenze - stenóza a. renalis (sklerózou, fibromuskulární dysplazií, zevní komprese)</ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">* feochromocytom </ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">* rebound fenomén po vysazení sympatolytických léků </ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">* Wilmsův tumor, neurofibromatóza </ins></div></td></tr> <tr><td colspan="2">&nbsp;</td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">* hypotyreóza</ins>, <ins class="diffchange diffchange-inline">hypertyreóza</ins></div></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>== Hlavní třídy antihypertensiv - (antihypertenziva I. třídy): ==</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>== Hlavní třídy antihypertensiv - (antihypertenziva I. třídy): ==</div></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* farmakoterapie nad 180/110 vždy &nbsp;</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* farmakoterapie nad 180/110 vždy &nbsp;</div></td></tr> <!-- diff generator: internal 2026-05-03 05:36:57 --> </table>

Kulan http://kulan.cz/index.php?title=Syst%C3%A9mov%C3%A1_hypertenze&diff=5041&oldid=prev 2011-10-28T23:29:25Z

<p></p> <table style="background-color: white; color:black;"> <col class='diff-marker' /> <col class='diff-content' /> <col class='diff-marker' /> <col class='diff-content' /> <tr valign='top'> <td colspan='2' style="background-color: white; color:black;">← Starší verze</td> <td colspan='2' style="background-color: white; color:black;">Verze z 28. 10. 2011, 23:29</td> </tr> <tr><td colspan="2" class="diff-lineno">Řádka 155:</td> <td colspan="2" class="diff-lineno">Řádka 155:</td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* nekouřit a nepít alkohol</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* nekouřit a nepít alkohol</div></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr> <tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div>== <del class="diffchange diffchange-inline">Hypertensní </del>krize ==</div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>== <ins class="diffchange diffchange-inline">Hypertenzní </ins>krize ==</div></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>akutní stav s výrazným vzestupem diastolického tlaku (často nad 130 - 140 mm Hg) &nbsp;</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>akutní stav s výrazným vzestupem diastolického tlaku (často nad 130 - 140 mm Hg) &nbsp;</div></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr> <tr><td colspan="2" class="diff-lineno">Řádka 182:</td> <td colspan="2" class="diff-lineno">Řádka 182:</td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* hypertenze u chronického srdečního selhávání</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* hypertenze u chronického srdečního selhávání</div></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr> <tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div>== Terapie ==</div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline">=</ins>== Terapie <ins class="diffchange diffchange-inline">=</ins>==</div></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>hrozí selhání orgánů, nutná urgentní léčba, hospitalizace, JIP</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>hrozí selhání orgánů, nutná urgentní léčba, hospitalizace, JIP</div></td></tr> <tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div>* captopril&nbsp; - první pomoc, krátce a rychle působící - 12,5 mg - 50 mg (u pacientů s chronickou medikací ACEI tak nutno výrazně vyšší dávky)</div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>* captopril&nbsp; - první pomoc, krátce a rychle působící <ins class="diffchange diffchange-inline">ACEI </ins>- 12,5 mg - 50 mg (u pacientů s chronickou medikací ACEI tak nutno výrazně vyšší dávky)</div></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* rilmenidin - (''Tenaxum'') - antagonista imidazolinových receptorů</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* rilmenidin - (''Tenaxum'') - antagonista imidazolinových receptorů</div></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* amlodipin - (''Agen'') BKK, 5-10 mg &nbsp;</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* amlodipin - (''Agen'') BKK, 5-10 mg &nbsp;</div></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr> <tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div>* nitroprusid sodný &nbsp;</div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>* nitroprusid sodný <ins class="diffchange diffchange-inline">- anorganická komplexní sůl trojmocného železa obsahující NO - arteriodilatace</ins></div></td></tr> <tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div>* urapidil &nbsp;</div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>* urapidil <ins class="diffchange diffchange-inline">- aktivace 5-HT&lt;sub&gt;1A&lt;/sub&gt; receptorů v oblongatě (sníží aktivitu sympatiku) + alfa1 blokátor (sníží cévní rezistenci)</ins></div></td></tr> <tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div>* labetolol &nbsp;</div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>* labetolol <ins class="diffchange diffchange-inline">- lipofilní neselektivní beta-blokátor se slabou ISA</ins></div></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* nitráty &nbsp;</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* nitráty &nbsp;</div></td></tr> <tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* furosemid &nbsp;</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>* furosemid &nbsp;</div></td></tr> <!-- diff generator: internal 2026-05-03 05:36:57 --> </table>

Kulan